Seeking a MCL-1 inhibitor

Cell Death and Differentiation

Volumn 20, Issue 11, 2013, Pages 1440-1441

  Brumatti, G ^a   Ekert, P G ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; ABT 199; ANTINEOPLASTIC AGENT; NAVITOCLAX; PROTEIN INHIBITOR; PROTEIN MCL 1; TW 37; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; EDITORIAL; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; LUNG SMALL CELL CANCER; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ANILINE COMPOUNDS; BENZAMIDES; HUMANS; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; SULFONAMIDES; SULFONES;

EID: 84885394280     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.114     Document Type: Editorial

References (10)

1. Oltersdorf T et al. Nature 2005; 435: 677-681.
2. van Delft MF et al. Cancer Cell 2006; 10: 389-399.
3. Beroukhim R et al. Nature 2010; 463: 899-905.
4. Glaser SP et al. Genes Dev 2012; 26: 120-125.
5. Varadarajan S et al. Cell Death Differ 2013; 20: 1475-1484.
6. Willis SN et al. Genes Dev 2005; 19: 1294-1305.
7. Mohammad RM et al. Clin Cancer Res 2007; 13: 2226-2235.
8. Certo M et al. Cancer Cell 2006; 9: 351-365.
9. Rinkenberger JL. Genes Dev 2000; 14: 23-27.
10. Opferman JT et al. Science 2005; 307: 1101-1104.